Arcus Biosciences annual asset turnover
2018
2019
2020
2021
2022
2023
2024
2025
Arcus Biosciences Asset Turnover Growth & History (RCUS)
Arcus Biosciences's asset turnover was 0.03 for fiscal 2025.
View full Arcus Biosciences company overviewArcus Biosciences annual asset turnover history
| Fiscal year | Period ended | Asset turnover | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.03 | −0.02 | −36.54% |
| 2024 | 2024-12-31 | 0.05 | 0.02 | +49.81% |
| 2023 | 2023-12-31 | 0.03 | 0.00 | +17.20% |
| 2022 | 2022-12-31 | 0.03 | −0.30 | −92.01% |
| 2021 | 2021-12-31 | 0.32 | 0.16 | +102.58% |
| 2020 | 2020-12-31 | 0.16 | 0.10 | +154.85% |
| 2019 | 2019-12-31 | 0.06 | 0.03 | +74.83% |
| 2018 | 2018-12-31 | 0.04 | — | — |
Arcus Biosciences quarterly asset turnover
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Asset turnover | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.06 | 0.02 | +40.15% |
| Q1 2026 | 2026-03-31 | 0.03 | −0.01 | −25.72% |
| Q4 2025 | 2025-12-31 | 0.03 | −0.02 | −36.54% |
| Q3 2025 | 2025-09-30 | 0.04 | — | — |
| Q2 2025 | 2025-06-30 | 0.04 | — | — |
| Q1 2025 | 2025-03-31 | 0.04 | — | — |
| Q4 2024 | 2024-12-31 | 0.05 | — | — |
| Q3 2022 | 2022-09-30 | 0.39 | 0.34 | +744.26% |
| Q2 2022 | 2022-06-30 | 0.34 | 0.21 | +155.73% |
| Q1 2022 | 2022-03-31 | 0.32 | 0.16 | +105.97% |
| Q4 2021 | 2021-12-31 | 0.32 | 0.17 | +103.84% |
| Q3 2021 | 2021-09-30 | 0.05 | −0.11 | −69.67% |
| Q2 2021 | 2021-06-30 | 0.13 | 0.09 | +223.39% |
| Q1 2021 | 2021-03-31 | 0.15 | 0.08 | +122.25% |
| Q4 2020 | 2020-12-31 | 0.16 | 0.10 | +153.27% |
| Q3 2020 | 2020-09-30 | 0.15 | 0.12 | +459.42% |
| Q2 2020 | 2020-06-30 | 0.04 | 0.01 | +18.63% |
| Q1 2020 | 2020-03-31 | 0.07 | 0.04 | +119.82% |
| Q4 2019 | 2019-12-31 | 0.06 | 0.03 | +74.83% |
| Q3 2019 | 2019-09-30 | 0.03 | — | — |
| Q2 2019 | 2019-06-30 | 0.04 | — | — |
| Q1 2019 | 2019-03-31 | 0.03 | — | — |
| Q4 2018 | 2018-12-31 | 0.04 | — | — |
Arcus Biosciences asset turnover trends
Over the last five fiscal years, Arcus Biosciences's asset turnover decreased from 0.16 to 0.03, a change of −0.13. The latest reported quarter, Q2 2026, shows 0.06.
About the metric
What asset turnover means
Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.
Calculation and source
How asset turnover is calculated
TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Arcus Biosciences source filings ↗Community posts
Arcus sets $17.50 share price for $250 million equity financing
Arcus Biosciences ($RCUS) priced an underwritten public offering of 14,285,715 new common shares at $17.50 apiece, targeting approximately $250 million in gross proceeds. The company is selling all of the shares, so the financing would add ...
Arcus reports additional kidney-cancer data supporting casdatifan development
Arcus Biosciences ($RCUS) released additional results from the ARC-20 program evaluating casdatifan in kidney cancer. Across pooled monotherapy cohorts involving 121 heavily pretreated patients, median overall survival was 35 months, median ...
